Jane Street’s Lifecore Biomedical LFCR Stock Holding History

Jane Street’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$153K	Buy	+29,076	New	+$146K	﹤0.01%	10336
2026 Q1	–	Sell	-119,445	Closed	-$977K	–	12368
2025 Q4	$977K	Buy	119,445 +53,173	+80%	+$393K	﹤0.01%	6173
2025 Q3	$488K	Buy	+66,272	New	+$501K	﹤0.01%	7920
2024 Q4	–	Sell	-36,246	Closed	-$179K	–	10054
2024 Q3	$179K	Buy	36,246 +18,277	+102%	+$95.5K	﹤0.01%	8718
2024 Q2	$92.2K	Sell	17,969 -277,618	-94%	-$1.64M	﹤0.01%	8757
2024 Q1	$1.57M	Buy	295,587 +159,357	+117%	+$1.14M	﹤0.01%	4572
2023 Q4	$843K	Buy	136,230 +100,851	+285%	+$700K	﹤0.01%	5870
2023 Q3	$267K	Sell	35,379 -59,571	-63%	-$544K	﹤0.01%	7239
2023 Q2	$918K	Buy	+94,950	New	+$580K	﹤0.01%	5330
2021 Q3	–	Sell	-14,749	Closed	-$166K	–	10373
2021 Q2	$166K	Buy	+14,749	New	+$170K	﹤0.01%	8963

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Jane Street's LFCR Position: Q2 2026 in Review

Jane Street opened a new position in Lifecore Biomedical (LFCR) in Q2 2026: 29,076 shares worth $153K. The stake represents ﹤0.01% of the portfolio and ranks #10336 among its holdings. This is a return to the name: Jane Street previously reported a position in LFCR as recently as Q4 2025.

Jane Street first reported a position in LFCR in Q2 2021 and has held it in 10 quarters since. The position peaked at $1.57M in Q1 2024. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Jane Street held 29,076 shares of Lifecore Biomedical worth $153K as of Q2 2026.
Lifecore Biomedical was a new Jane Street position in Q2 2026.
Lifecore Biomedical made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10336 holding.
Jane Street first reported a position in Lifecore Biomedical in Q2 2021 and has held it in 10 quarters since.
Jane Street's Lifecore Biomedical position peaked at $1.57M in Q1 2024.
99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.